What does Meribank Biotech Co., Ltd do?

Meribank Biotech Co., Ltd (4724.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4724.TWO's market cap?

Meribank Biotech Co., Ltd (4724.TWO) has a market capitalization of approximately $894.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4724.TWO pay a dividend?

No — Meribank Biotech Co., Ltd (4724.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 4724.TWO profitable?

Meribank Biotech Co., Ltd (4724.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

4724.TWO

Meribank Biotech Co., Ltd

TWO·Biotechnology · Healthcare

NT$9.32NT$0.00+0.00%

Market capNT$894.50M·Market closed·Aug 26 6:58 AM UTC

Price Chart

NT$9.32+NT$0.00 (+0.00%)today

−69.94%CAGR −31.35%

Select date range

FromTo

Jun 16, 2023Jun 16, 2023 → Aug 26, 2026· 3.2 yrsAug 26, 2026

Key Metrics

4724.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$408.48M

Net Income−NT$135.08M

Net Margin−33.1%

Operating Cash FlowNT$70.04M

Capital ExpendituresNT$9.72M

Free Cash FlowNT$60.31M

Return on Equity−11.5%

Return on Invested Capital−2.4%

Net DebtNT$893.80M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4724.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4724.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4724.TWO and 80,000+ other tickers.

About Meribank Biotech Co., Ltd

Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.

CEO: Jian-Fang Cai
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 142
Website: www.meribank.com.tw

Peers

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Cap

NT$2.8B

6709.TWO

Advagene Biopharma Co., Ltd.

Cap

NT$1.8B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4724.TWO

What does Meribank Biotech Co., Ltd do?: Meribank Biotech Co., Ltd (4724.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4724.TWO's market cap?: Meribank Biotech Co., Ltd (4724.TWO) has a market capitalization of approximately $894.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4724.TWO pay a dividend?: No — Meribank Biotech Co., Ltd (4724.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 4724.TWO profitable?: Meribank Biotech Co., Ltd (4724.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.